HCA Healthcare (NYSE:HCA) Price Target Cut to $500.00 by Analysts at Argus

HCA Healthcare (NYSE:HCA) had its price objective cut by equities researchers at Argus from $560.00 to $500.00 in a research report issued on Monday,MarketScreener reports. The firm currently has a “buy” rating on the stock. Argus’ price target indicates a potential upside of 15.88% from the stock’s current price.

Several other research analysts have also recently issued reports on the stock. Oppenheimer dropped their target price on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Leerink Partners dropped their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Wall Street Zen downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday. TD Cowen cut their price target on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating on the stock in a report on Monday, April 27th. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research report on Tuesday, April 28th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $517.82.

HCA Healthcare Price Performance

Shares of HCA stock opened at $431.47 on Monday. The company’s 50-day simple moving average is $497.66 and its two-hundred day simple moving average is $486.41. HCA Healthcare has a one year low of $330.00 and a one year high of $556.52. The company has a market capitalization of $96.00 billion, a P/E ratio of 14.83, a P/E/G ratio of 1.37 and a beta of 1.19.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same period last year, the company earned $6.45 EPS. The firm’s revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts expect that HCA Healthcare will post 30.05 EPS for the current fiscal year.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Jennifer Berres sold 8,020 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the transaction, the senior vice president owned 11,993 shares in the company, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the sale, the senior vice president directly owned 44,379 shares in the company, valued at $22,411,395. This trade represents a 8.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 15,214 shares of company stock valued at $7,797,595. 1.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of HCA. Palisade Asset Management LLC purchased a new stake in HCA Healthcare in the third quarter valued at approximately $26,000. Holos Integrated Wealth LLC acquired a new stake in HCA Healthcare during the 4th quarter valued at approximately $29,000. Ares Financial Consulting LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter worth $31,000. Cedar Mountain Advisors LLC acquired a new position in HCA Healthcare during the first quarter valued at $33,000. Finally, JPL Wealth Management LLC purchased a new position in shares of HCA Healthcare during the 3rd quarter valued at about $33,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.